Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimens. - Markman,M.; Rose,P.G.; Jones,E. (J Clin Oncol, 1998)